Background: Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis (TB) and latent TB infection (LTBI), which limit their use in TB endemic areas. Subjects with QuantiFERON-TB (QFT) results around the diagnostic cut-off more likely show inconsistent results on serial testing which makes the interpretation of the assay difficult. We have studied potential biomarkers in patients with various stages of TB infection and with borderline QFT tests compared to those with higher values. Methods: 27 soluble biomarkers were analysed in QFT supernatants from patients with active TB (n = 18), individuals with LTBI (n = 48) and from QFT negative controls (n = 16) by the Multiplex bead assay. The LTBI group was classified...
Mycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamm...
Borderline interferon-gamma (IFN-γ) results (near the cut-off level 0.35 IU/ml) occur in QuantiFERON...
AbstractEffective control of tuberculosis (TB) includes discrimination of subjects with active TB fr...
Background: Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis ...
Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis (TB) and lat...
Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis (TB) and lat...
Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) t...
Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) t...
International audienceObjectives We analyzed the results of the QuantiFERON Glod Plus assay (QFT) an...
International audienceObjectives We analyzed the results of the QuantiFERON Glod Plus assay (QFT) an...
Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IG...
The development of clinically relevant biomarkers is important for diagnosing latent tuberculosis in...
RATIONALE: Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin skin test ...
Interferon gamma release assays (IGRAs) could accurately diagnose Mycobacterium tuberculosis (M.tube...
Summary: The tuberculin skin test (TST) and interferon-gamma release assays (IGRA), namely, the Quan...
Mycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamm...
Borderline interferon-gamma (IFN-γ) results (near the cut-off level 0.35 IU/ml) occur in QuantiFERON...
AbstractEffective control of tuberculosis (TB) includes discrimination of subjects with active TB fr...
Background: Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis ...
Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis (TB) and lat...
Interferon gamma release assays (IGRAs) do not discriminate between active tuberculosis (TB) and lat...
Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) t...
Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) t...
International audienceObjectives We analyzed the results of the QuantiFERON Glod Plus assay (QFT) an...
International audienceObjectives We analyzed the results of the QuantiFERON Glod Plus assay (QFT) an...
Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IG...
The development of clinically relevant biomarkers is important for diagnosing latent tuberculosis in...
RATIONALE: Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin skin test ...
Interferon gamma release assays (IGRAs) could accurately diagnose Mycobacterium tuberculosis (M.tube...
Summary: The tuberculin skin test (TST) and interferon-gamma release assays (IGRA), namely, the Quan...
Mycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamm...
Borderline interferon-gamma (IFN-γ) results (near the cut-off level 0.35 IU/ml) occur in QuantiFERON...
AbstractEffective control of tuberculosis (TB) includes discrimination of subjects with active TB fr...